Molecular Testing

 

Hereditary Cancer Genetics(CGx)

  • A test that helps identify people at increased risk for cancer due to hereditary factors

  • Clinicians can assess personal cancer risk, review potential risk factors, provide recommendations about appropriate prevention

  • Who Should Be Screened?

    • A personal history of cancer at a young age

    • One to two first or second degree relatives diagnosed with cancer before the age of 50

    • Relatives diagnosed with ovarian cancer

    • Relatives diagnosed with male breast cancer

SureGx

Pharmacogenetics (PGx)

  • Pharmacogenetics testing test that tells you how your genes affect your body’s response to medications

  • Specifically for pain, psychiatric disorders, and cardiovascular diseases

  • Individuals should be tested if they have ever had a lack of symptom relief and adverse, unpleasant or intolerable response to their current medication

Parkinsons / Alzheimers / Dementia (PAD)

  • ​Genetic information will be help physicians making better treatment and management choices 

  • Patients will have better understanding of the disorder by genetic and psychosocial counseling 

  • Other potential benefits include research study enrollment and support programs for caregivers and patients

  • More than 50% increased risk seen in close relative of individuals with confirmed pathogenic mutations

  • Family screening can help in identifying genetic predisposition to start timely management   

SureDx

Respiratory Pathogen Panel (RPP)

Urinary Tract Infection (UTI)

Wound Testing